Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2421Fax+1 415-353-2467- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2006 - 2009
- Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
- Duke University School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2005 - 2025
- MA State Medical License 2005 - 2006
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen Start of enrollment: 2009 Nov 01
- Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML) Start of enrollment: 2011 Nov 21
Publications & Presentations
PubMed
- LNK/as a novel driver in juvenile myelomonocytic leukemia.Astrid Wintering, Anna Hecht, Julia Meyer, Eric B Wong, Juwita Hübner, Sydney Abelson, Kira Feldman, Vanessa E Kennedy, Cheryl A C Peretz, Deborah L French, Jean Ann M...> ;Haematologica. 2023 Dec 28
- FLT3 targeting in the modern era: from clonal selection to combination therapies.Kennedy, V., Smith, C.> ;International Journal of Hematology. 2023 Dec 19
- 1 citationsAllosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML.Bogdan Popescu, Carlos Stahlhut, Theodore C Tarver, Sydney Wishner, Bianca J Lee, Cheryl A C Peretz, Cuyler Luck, Paul Phojanakong, Juan Antonio Camara Serrano, Henry ...> ;Cell Reports. Medicine. 2023 Nov 21
- Join now to see all
Abstracts/Posters
- Combined Single-Cell DNA Genotyping and Protein Quantification (DAb-seq) in Acute Myeloid Leukemias Reveals Distinct Immunophenotypic Subsets Among Pathogenic ClonesCatherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Single Cell Sequencing Reveals Evolution of Tumor Heterogeneity of Acute Myeloid Leukemia on QuizartinibCatherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative NeoplasmsCatherine C. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Astellas Presents New Data on XOSPATA® (Gilteritinib) in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual MeetingDecember 2nd, 2019
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
- Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: